Use of g-csf to reduce acute rejection

Details Use of g-csf to reduce acute rejection Use of g-csf to reduce acute rejection

A - Human Necessities

61

K

A61K 38/19 (2006.01)

Patent

CA 2187938

Reduction of occurrence of acute rejection of organ transplants is achieved by treatment with a G-CSF protein product.

La fréquence des rejets brutaux d'organes transplantés peut être réduite par un traitement par des produits à base de protéine G-CSF.

Affiliated with

Also associated with

Rating

Use of g-csf to reduce acute rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of g-csf to reduce acute rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of g-csf to reduce acute rejection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1447020